Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

NCT06289673 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

850

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia
Lymphoblastic Lymphoma
Mixed Phenotype Acute Leukemia

Interventions

DRUG: Dexamethasone
DRUG: Vincristine
DRUG: Daunorubicin
DRUG: Intrathecal triple therapy (methotrexate + hydrocortisone + cytarabine)
DRUG: Methotrexate
DRUG: Cytarabine

Sponsor

St. Jude Children's Research Hospital